由於各種醫療保健機構對高效、安全的靜脈 (IV) 治療的需求不斷增加，靜脈通路設備市場正在擴大。靜脈注射裝置對於輸送液體、藥物、血液製品和營養至關重要，特別是對於重症監護、醫院和門診手術中心的患者。推動市場發展的因素包括慢性病盛行率上升、人口老化、靜脈注射手術需求激增。此外，技術的進步也顯著改善了靜脈注射設備的設計和安全特性。例如，無針血液採集系統（如 BD 的 PIVO Pro）的開發以及安全靜脈導管（如 B. Braun 的 Introcan Safety 2）的創新有助於最大限度地降低針刺傷的風險並防止接觸血源性病原體。此外，公司正致力於改善靜脈導管的功能，例如多通路血液控制和雙腔導管等功能。連網輸液幫浦等智慧技術的整合正在提高病患安全性並減少醫療錯誤。隨著全球尤其是新興地區醫療保健基礎設施的改善，靜脈通路設備市場預計將在未來幾年內大幅成長。
Frequently Asked Questions
The market is segmented based on Segmentation, By Product (Intravenous Catheters, Intravenous Infusion Pumps, and Intravenous Needles), End User (Hospitals and Clinics, Ambulatory Surgery Centers, Dialysis Centers, Home Care, and Others), Application (Medication Administration, Administration of Fluid and Nutrition, Transfusion of Blood Products, and Diagnostic Testing) – Industry Trends and Forecast to 2032
.
The Global Intravenous Access Devices Market size was valued at USD 7.28 USD Billion in 2024.
The Global Intravenous Access Devices Market is projected to grow at a CAGR of 5.78% during the forecast period of 2025 to 2032.
The major players operating in the market include BD, B. Braun Melsungen AG, Teleflex Incorporated., Medtronic, Smiths Group PLC, Pfizer Inc., Fresenius Medical Care AG & Co. KGaA, Baxter., Siemens Healthcare Private Limited, Terumo Medical Corporation, NIPRO, Edwards Lifesciences Corporation., General Electric, AngioDynamics., Cook, Deltamed., Galt Medical Corp., ICU MedicalInc., VYGON LTD, Retractable TechnologiesInc., .
The market report covers data from the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E., South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
